AngioDynamics, Inc.

$11.81+3.23%(+$0.37)
TickerSpark Score
62/100
Mixed
67
Valuation
40
Profitability
60
Growth
64
Health
80
Momentum

Built from real-time financials and updated daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a ANGO research report →

52-Week Range61% of range
Low $8.36
Current $11.81
High $13.99

Companywww.angiodynamics.com

AngioDynamics, Inc. designs, manufactures, and sells various medical, surgical, and diagnostic devices used by professional healthcare providers for the treatment of peripheral vascular disease and vascular access; and for use in oncology and surgical settings in the United States and internationally. The company provides NanoKnife ablation systems for the surgical ablation of soft tissues; solero microwave tissue ablation systems; and radiofrequency ablation products for ablating solid cancerous or benign tumors.

CEO
James C. Clemmer
IPO
2004
Employees
748
HQ
Latham, NY, US

Price Chart

+24.08% · this period
$13.64$11.02$8.40May 20Nov 18May 20

Valuation

Market Cap
$487.98M
P/E
-15.65
P/S
1.56
P/B
2.83
EV/EBITDA
-115.78
Div Yield
0.00%

Profitability

Gross Margin
53.45%
Op Margin
-8.08%
Net Margin
-10.00%
ROE
-17.65%
ROIC
-13.03%

Growth & Income

Revenue
$292.50M · -3.76%
Net Income
$-33,993,000 · 81.56%
EPS
$-0.83 · 81.92%
Op Income
$-39,954,000
FCF YoY
56.99%

Performance & Tape

52W High
$13.99
52W Low
$8.36
50D MA
$10.79
200D MA
$11.13
Beta
0.37
Avg Volume
392.33K

Get TickerSpark's AI analysis on ANGO

Pro members can request AI-generated analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.

Get Pro Access →

30-day money-back guarantee · cancel anytime

Recent Insider Transactions

DateInsiderTypeShares
Oct 21, 25Weiss Lawrence Tbuy10,000
Oct 13, 25Trowbridge Stephen Abuy890
Oct 9, 25Clemmer James Cbuy10,000
Jul 19, 25Trowbridge Stephen Aother2,585
Jul 20, 25Trowbridge Stephen Aother717
Jul 21, 25Trowbridge Stephen Aother667
Jul 19, 25Piccinini Lauraother1,983
Jul 20, 25Piccinini Lauraother616
Jul 19, 25Nighan Warren JRother735
Jul 20, 25Nighan Warren JRother251

Our ANGO Coverage

We haven't published any research on ANGO yet

For a full analyst-grade research report — grades, price targets, full financials, chart analysis — generate one on demand.

Generate ANGO Report →

Similar Companies